Tasheda Navarro
Technik-/Wissenschafts-/F&E-Leiter bei VINCERX PHARMA, INC.
Profil
Tasheda Navarro is currently the Vice President-Clinical Operations at Vincerx Pharma, Inc. Prior to this, she worked as the Senior Director-Clinical Operations at Acerta Pharma LLC from 2014 to 2020, Senior Clinical Trial Manager at Pharmacyclics LLC from 2010 to 2012, and Clinical Trial Manager at Bavarian Nordic, Inc. from 2012 to 2014.
Ms. Navarro received her undergraduate degree from the University of Washington in 1999.
Aktive Positionen von Tasheda Navarro
| Unternehmen | Position | Beginn |
|---|---|---|
| VINCERX PHARMA, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ehemalige bekannte Positionen von Tasheda Navarro
| Unternehmen | Position | Ende |
|---|---|---|
| Acerta Pharma LLC | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2020 |
Bavarian Nordic, Inc.
 Bavarian Nordic, Inc. Miscellaneous Commercial ServicesCommercial Services Bavarian Nordic, Inc. engages in researching and manufacturing drugs to treat cancer. The company is headquartered in Morrisville, NC. | Corporate Officer/Principal | 01.03.2014 |
| PHARMACYCLICS, INC. | Corporate Officer/Principal | 01.03.2012 |
Ausbildung von Tasheda Navarro
| University of Washington | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| VINCERX PHARMA, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
| Acerta Pharma LLC | |
Bavarian Nordic, Inc.
Bavarian Nordic, Inc. Miscellaneous Commercial ServicesCommercial Services Bavarian Nordic, Inc. engages in researching and manufacturing drugs to treat cancer. The company is headquartered in Morrisville, NC. | Commercial Services |
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Pharmacyclics LLC engages in developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. It has product candidates in clinical development and several preclinical molecules in optimization. The company was founded by Jonathan Sessler and Richard Miller in 1991 and is headquartered in Sunnyvale, CA. | Health Technology |
